NIH-funded research R01 grant

Precision medicine for inherited retinal degenerations

Funded at Massachusetts Eye and Ear Infirmary · NIH-11380821 · Data updated 2026-11-12

A patient-facing overview of a research project to uncover genetic causes of inherited retinal degenerations and develop therapies to prevent vision loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts Eye and Ear Infirmary
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 8, 1999
Project endJuly 31, 2028
Funding year2026
Award (this year)$692,317
NIH project number5R01EY012910-29
Project IDNIH-11380821 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with inherited retinal degenerations or suspected genetic causes of vision loss who may benefit from future genetic or therapeutic approaches.

Less likely to help

Patients without IRD or without a genetic basis for their vision loss may not directly benefit from this research.

What this research studies

This project aims to find the genetic causes of inherited retinal degenerations (IRDs) and understand how gene mutations lead to retinal damage. Researchers will explore why about one-third of IRD patients still lack a genetic diagnosis and how different gene changes affect light-sensing cells and supporting cells in the eye. By combining genetic findings with studies of disease mechanisms, the work seeks to pave the way for gene-based and neuroprotective therapies that could preserve or restore vision. The project is conducted at the Massachusetts Eye and Ear Infirmary in Boston, led by Dr. Eric A. Pierce, with a focus on translating discoveries into new treatments for people with IRDs.

Why it matters

Potential benefit: If successful, this research could enable precise genetic diagnoses and guide the development of targeted therapies to prevent or slow vision loss in IRD patients.

How similar studies have gone: Previous IRD genetic studies have identified many disease genes, and advances in genetic therapies show promise for broader application.

Where this research is happening

  • Massachusetts Eye and Ear Infirmary
    Boston, United States
    Active

Researchers

  • Principal investigator: Pierce, Eric a — Massachusetts Eye and Ear Infirmary
  • Study coordinator: Pierce, Eric a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.